DİŞ HEKİMLİĞİNDE ANTİPLATELET VE ANTİKOAGÜLAN KULLANAN HASTALARIN PERİOPERATİF YÖNETİMİ

Öz

Oral antikoagülanlar (OAK) ve antiplatelet ajanlar, kardiyovasküler hastalıkların tedavisinde yaygın olarak kullanılmaktadır. Bu ilaçları kullanan hastaların diş hekimliği uygulamalarında kanama yönetimi önemli bir klinik sorundur. Bu derleme, dental girişimlerde kanama kontrolü için mevcut kılavuzları ve güncel yaklaşımları incelemekte, minimal invaziv tekniklerin ve lokal hemostatik ajanların etkinliğini değerlendirmektedir.

Anahtar Kelimeler

• oral antikoagülanlar
• antiplatelet tedavi
• dental cerrahi
• kanama yönetimi
• lokal hemostatik ajanlar
• yeni nesil oral antikoagülanlar

PERIOPERATIVE MANAGEMENT OF PATIENTS USING ANTIPLATELETS AND ANTICOAGULANTS IN DENTISTRY

Öz

Oral anticoagulants (OACs) and antiplatelet agents are widely used in the treatment of cardiovascular diseases. Bleeding management during dental procedures in patients using these medications is a significant clinical challenge. This review examines current guidelines and recent approaches to bleeding control in dental interventions, evaluating the effectiveness of minimally invasive techniques and local hemostatic agents.

Anahtar Kelimeler

• oral anticoagulants
• antiplatelt therapy
• dental surgery
• bleeding management
• local hemostatic agents
• new generation oral anticoagulants

Kaynakça

1. Abdullah, W. & Khalil, H.S., 2014. Dental extraction in patients on warfarin treatment: a series of 35 patients. Clinical, Cosmetic and Investigational Dentistry, 6, ss. 1-5.
2. Akyüz, S. & Atalay, T., 1991. Kanama ve Pıhtılaşma Zamanlarının Uzamasına Neden Olan Hastalıkların Dişhekimliği Açısından Önemi. Marmara Üniversitesi Diş Hekimliği Fakültesi Dergisi, 25(4), ss. 215-219.
3. Aronson, J.K., 2016. Meyler's side effects of drugs: The international encyclopedia of adverse drug reactions and interactions. 16. Baskı. Amsterdam: Elsevier, ss. 513-515.
4. Bulut, A., Bulut, Ö.E. & Erbaş, D., 2013. Dişhekimliği hastalarında yeni nesil oral antikoagülan kullanım prensipleri. ADO Klinik Bilimler Dergisi, 7(2), ss. 1485-1500.
5. Costantinides, F., Rizzo, R., Pascazio, L. & Maglione, M., 2016. Managing patients taking novel oral anticoagulants (NOAs) in dentistry: A discussion paper on clinical implications. BMC Oral Health, 16, 5.
6. Dézsi, C.A., Dézsi, B.B. & Dézsi, A.D., 2017. Management of dental patients receiving antiplatelet therapy or chronic oral anticoagulation: A review of the latest evidence. European Journal of General Practice, 23(1), ss. 196-201.
7. Doğanay, Ö., Atalay, B., Karadağ, E., Ağa, U. & Tuğrul, M., 2018. Bleeding frequency of patients taking ticagrelor, aspirin, clopidogrel, and dual antiplatelet therapy after tooth extraction and minor oral surgery. The Journal of the American Dental Association, 149(2), ss. 132-138.
8. Garcia, D., Libby, E. & Crowther, M.A., 2010. The new oral anticoagulants. Blood, 115(1), ss. 15-20.

9. Karen, W., Carinda, F. & Rajan, R., 2019. Antikoagülan ve antiplatelet ilaçlar. In: A.U., Ç.H.K. & D. Dikmen, eds. Farmakoloji. 1. Baskı. İstanbul: Nobel Tıp Kitabevleri, ss. 268-287.
10. Koh, H.H., Lim, Y.J. & Seneviratne, C.J., 2018. Local haemostatic measures after tooth removal in patients on antithrombotic therapy: A systematic review. Clinical Oral Investigations, 22(6), ss. 2343-2352.
11. Lahham, E., Abu Ta’a, M., Hayek, A. & Lahham, C., 2023. Dental implant surgery for patients receiving non-vitamin K antagonist oral anticoagulants (NOACs); Clinical considerations and management: A mini-review. Open Dentistry Journal, 17, ss. 1-8.
12. Madsen, P.J., Stenbøg, E.V., Thayssen, P. & Hørding, M.L., 2017. Pragmatic approach to manage new oral anticoagulants in patients undergoing dental extractions: A prospective case-control study. Clinical Oral Investigations, 21(3), ss. 857-864.
13. Miclotte, I., Vanhaverbeke, M., Agbaje, J.O., Legrand, P., Vanassche, T., Verhamme, P. & Politis, C., 2017. Pragmatic approach to manage new oral anticoagulants in patients undergoing dental extractions: a prospective case-control study. Clinical Oral Investigations, 21(7), ss. 2183-2188.
14. Nathwani, S. & Wanis, C., 2017. Novel oral anticoagulants and exodontia: The evidence. British Dental Journal, 222(8), ss. 623-628.
15. Schmitt, C.M., Rusche, B., Clemm, R., Neukam, F.W. & Buchbender, M., 2020. Management of anticoagulated patients in dentoalveolar surgery: A clinical comparative study. Clinical Oral Investigations, 24(8), ss. 2653-2662.
16. Solomon, E. & Brennan, M.T., 2018. Anticoagulants are dental friendly. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 125(2), ss. 103-105.
17. Statman, B.J., 2023. Perioperative management of oral antithrombotics in dentistry and oral surgery: Part 2. Anesthesia Progress, 70(1), ss. 37-48.
18. Thrombosis Canada, 2021. Use and interpretation of laboratory coagulation tests in patients who are receiving a new oral anticoagulant (Dabigatran, Rivaroxaban, Apixaban).
19. Ulugöl, A., Karadağ, H., Dökmeci, D., Gündüz, Ö. & Topuz, R.D., 2018. Farmakoloji. 1. Baskı. İstanbul: Nobel Tıp Kitabevleri, ss. 177-186.
20. U.S. Food and Drug Administration, 2015. FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes.